List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #47,901 to #47,950.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. ST segment elevation myocardial infarction → ST elevation myocardial infarction
  2. ST segment morphology → ST interval
  3. ST segments → ST interval
  4. SU101 → Leflunomide (patient information)
  5. SU11248 → Sunitinib
  6. SU5416 → Semaxanib
  7. SUBEPENDYMAL GIANT CELL ASTROCYTOMA → Subependymal giant cell astrocytoma
  8. SUICIDAL BEHAVIOR → Suicide
  9. SULT2A1 → Alcohol sulfotransferase
  10. SUMOylation → SUMO protein
  11. SUNDS → Brugada syndrome
  12. SUR1 → Sulfonylurea receptor
  13. SUR2A → Sulfonylurea receptor
  14. SUR2B → Sulfonylurea receptor
  15. SURVIVE → Survival Of Patients With Acute Heart Failure In Need Of Intravenous Inotropic Support
  16. SUTAMI → Double-Blind Multicenter Comparison Of The Efficacy And Safety Of Saruplase And Urokinase In The Treatment Of Acute Myocardial Infarction: Report Of The Sutami Study Group
  17. SVC → Superior vena cava syndrome
  18. SVCO → Superior vena cava syndrome
  19. SVCS → Superior vena cava syndrome
  20. SVC Syndrome → Superior vena cava syndrome
  21. SVC obstruction → Superior vena cava syndrome
  22. SVC syndrome → Superior vena cava syndrome
  23. SVG → Saphenous vein graft
  24. SVG Anatomy → Saphenous vein graft anatomy
  25. SVGs → Saphenous vein graft
  26. SVR → Vascular resistance
  27. SVT → Supraventricular tachycardia
  28. SVT resident survival guide → Narrow complex tachycardia resident survival guide
  29. SVT vs VT → Wide complex tachycardia differential diagnosis
  30. SVT with aberrancy → Wide complex tachycardias
  31. SVT with aberrant conduction → Wide complex tachycardias
  32. SVTs → Supraventricular tachycardia
  33. SVZ → Subventricular zone
  34. SWEDES → Swedish Early Decision Trial
  35. SWIFT → Should We Intervene Following Thrombolysis?
  36. SWISH → Swedish Isradipine Study In Hypertension
  37. SWISSI II → Swiss Interventional Study On Silent Ischemia Type II
  38. SWITCH → Switching From Lovenox To Angiomax In Patients With Acute Coronary Syndromes Without St Elevation Undergoing Pci
  39. SWORD → Survival With Oral D-Sotalol Trial
  40. SYMBIOT III → A Prospective, Randomized Trial Of A Self-Expanding Ptfe Stent Graft During Svg Intervention - Late Results
  41. SYMPHONY I → Sibrafiban Versus Aspirin To Yield Maximum Protection From Ischemic Heart Events Post-Acute Coronary Syndromes
  42. SYMPHONY II → Randomized Trial Of Aspirin, Sibrafiban, Or Both For Secondary Prevention After Acute Coronary Syndromes
  43. SYNCOPE → Syncope
  44. SYNERGY → Superior Yield Of The New Strategy Of Enoxaparin, Revascularization, And Glycoprotein IIb/IIia Inhibitors
  45. SYNERGY-PCI → A Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention
  46. SYNTAX → Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery
  47. SYNTAX Score → Synergy Between Percutaneous Coronary Intervention With Taxus And Cardiac Surgery#SYNTAX score
  48. SYNTAX score → Synergy Between Percutaneous Coronary Intervention With Taxus And Cardiac Surgery
  49. SZA → Schizoaffective disorder
  50. S aureus → Staphylococcus aureus

View ( | ) (20 | 50 | 100 | 250 | 500)